Investing.com - Acutus Medical (OTC: AFIB) reported third quarter EPS of $-0.0300, $0.38 better than the analyst estimate of $-0.4100. Revenue for the quarter came in at $5.27M versus the consensus estimate of $7.76M.
Acutus Medical's stock price closed at $0.06. It is up 68.4500% in the last 3 months and down -69.7100% in the last 12 months.
Acutus Medical saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Acutus Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Acutus Medical's Financial Health score is "fair performance".
Check out Acutus Medical's recent earnings performance, and Acutus Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar